Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Merck
Dow
McKesson
Harvard Business School

Last Updated: June 28, 2022

NUVARING Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Nuvaring patents expire, and what generic alternatives are available?

Nuvaring is a drug marketed by Organon Sub Merck and is included in one NDA.

The generic ingredient in NUVARING is ethinyl estradiol; etonogestrel. There are twenty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; etonogestrel profile page.

Drug patent expirations by year for NUVARING
Drug Prices for NUVARING

See drug prices for NUVARING

Drug Sales Revenue Trends for NUVARING

See drug sales revenues for NUVARING

Recent Clinical Trials for NUVARING

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lupin Research IncPhase 2
Andrea Roe, MD, MPHPhase 4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 4

See all NUVARING clinical trials

Pharmacology for NUVARING
Paragraph IV (Patent) Challenges for NUVARING
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
NUVARING Vaginal Ring ethinyl estradiol; etonogestrel 0.015 mg/24 hour 0.12 mg/24 hour 021187 1 2013-06-17

US Patents and Regulatory Information for NUVARING

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Sub Merck NUVARING ethinyl estradiol; etonogestrel RING;VAGINAL 021187-001 Oct 3, 2001 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for NUVARING

See the table below for patents covering NUVARING around the world.

Country Patent Number Title Estimated Expiration
Poland 325774 See Plans and Pricing
Israel 123813 DRUG DELIVERY SYSTEM FOR TWO OR MORE ACTIVE SUBSTANCES See Plans and Pricing
Turkey 9800648 See Plans and Pricing
Hong Kong 1016886 See Plans and Pricing
Russian Federation 2206325 СИСТЕМА ДОСТАВКИ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ ДЛЯ ДВУХ ИЛИ БОЛЕЕ АКТИВНЫХ ВЕЩЕСТВ (DRUG DELIVERY SYSTEM FOR TWO OR MORE ACTIVE SUBSTANCES) See Plans and Pricing
Australia 6075198 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for NUVARING

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1453521 CA 2016 00016 Denmark See Plans and Pricing PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
1214076 C01214076/01 Switzerland See Plans and Pricing PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008
1380301 CA 2009 00017 Denmark See Plans and Pricing PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629
0398460 C300221 Netherlands See Plans and Pricing PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
0771217 07C0001 France See Plans and Pricing PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804
1453521 300814 Netherlands See Plans and Pricing PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Harvard Business School
Moodys
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.